These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 10716151)
21. Epstein-Barr virus (EBV) genotypes among human immunodeficiency virus (HIV)-related B-cell lymphomas and B-cell post-transplant lymphoproliferative disorders (B-PTLD)--late-onset lymphomas, especially in the HIV setting, are associated with type-B-EBV. Ibrahim HA; Menasce LP; Pomplun S; Burke M; Bower M; Naresh KN Eur J Haematol; 2010 Sep; 85(3):227-30. PubMed ID: 20408873 [TBL] [Abstract][Full Text] [Related]
22. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055 [TBL] [Abstract][Full Text] [Related]
25. Posttransplant lymphoproliferative disorder after umbilical cord blood transplantation in children. Gong JZ; Bayerl MG; Sandhaus LM; Sebastian S; Rehder CW; Routbort M; Lagoo AS; Szabolcs P; Chiu J; Comito M; Buckley PJ Am J Surg Pathol; 2006 Mar; 30(3):328-36. PubMed ID: 16538052 [TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation. Chen DB; Song QJ; Chen YX; Chen YH; Shen DH Int J Hematol; 2013 Jan; 97(1):117-24. PubMed ID: 23255160 [TBL] [Abstract][Full Text] [Related]
27. Central Nervous System Involvement in Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation. Balaguer-Rosello A; Piñana JL; Bataller L; Montoro J; Romero S; Navarro I; Lorenzo I; Andreu R; Guerreiro M; Aguilar C; Gorriz D; Dominguez L; de la Puerta R; Gómez I; Solves P; Jarque I; Sanz MÁ; Sanz G; Sanz J Transplant Cell Ther; 2021 Mar; 27(3):261.e1-261.e7. PubMed ID: 33781531 [TBL] [Abstract][Full Text] [Related]
28. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113 [TBL] [Abstract][Full Text] [Related]
29. Bone marrow findings of 23 Korean post-transplant lymphoproliferative disorder patients: a single-center experience. Cho MC; Park CJ; Huh J; Chi HS; Jang S; Suh C; Lee KH; Lee JH; Seo JJ; Im HJ Clin Transplant; 2012; 26(4):E381-7. PubMed ID: 22694766 [TBL] [Abstract][Full Text] [Related]
30. Molecular epidemiology of EBNA-1 substrains of Epstein-Barr virus in posttransplant lymphoproliferative disorders which have infrequent p53 mutations. Greiner TC; Abou-Elella AA; Smir BN; Orazi A; Hinrichs S; Anderson J; Gross T; Bierman P; Hauke R Leuk Lymphoma; 2000 Aug; 38(5-6):563-76. PubMed ID: 10953978 [TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironment. Overkamp M; Granai M; Bonzheim I; Steinhilber J; Schittenhelm J; Bethge W; Quintanilla-Martinez L; Fend F; Federmann B Virchows Arch; 2021 Jun; 478(6):1135-1148. PubMed ID: 33324999 [TBL] [Abstract][Full Text] [Related]
32. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder. Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104 [TBL] [Abstract][Full Text] [Related]
34. Identification of rare Epstein-Barr virus infected memory B cells and plasma cells in non-monomorphic post-transplant lymphoproliferative disorders and the signature of viral signaling. Shaknovich R; Basso K; Bhagat G; Mansukhani M; Hatzivassiliou G; Murty VV; Buettner M; Niedobitek G; Alobeid B; Cattoretti G Haematologica; 2006 Oct; 91(10):1313-20. PubMed ID: 17018379 [TBL] [Abstract][Full Text] [Related]
35. Thoracic presentations of posttransplant lymphoproliferative disorders. Halkos ME; Miller JI; Mann KP; Miller DL; Gal AA Chest; 2004 Dec; 126(6):2013-20. PubMed ID: 15596707 [TBL] [Abstract][Full Text] [Related]
37. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124 [TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course. Oertel S; Trappe RU; Zeidler K; Babel N; Reinke P; Hummel M; Jonas S; Papp-Vary M; Subklewe M; Dörken B; Riess H; Gärtner B Ann Hematol; 2006 Jul; 85(7):478-84. PubMed ID: 16586109 [TBL] [Abstract][Full Text] [Related]
39. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients. Shapiro NL; Tang CG; Bhattacharyya N Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960 [TBL] [Abstract][Full Text] [Related]
40. B-cell posttransplant lymphoproliferative disorders in heart and/or lungs recipients: clinical and molecular-histogenetic study of 17 cases from a single institution. Lucioni M; Capello D; Riboni R; Ippoliti G; Campana C; Bandiera L; Arcaini L; Rossi D; Cerri M; Dionigi P; Lazzarino M; Magrini U; Viganò M; Gaidano G; Paulli M Transplantation; 2006 Oct; 82(8):1013-23. PubMed ID: 17060848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]